US20020049498A1 - In situ bioprosthetic filler and methods, particularly for the in situ formation of vertebral disc bioprosthetics - Google Patents

In situ bioprosthetic filler and methods, particularly for the in situ formation of vertebral disc bioprosthetics Download PDF

Info

Publication number
US20020049498A1
US20020049498A1 US09983537 US98353701A US2002049498A1 US 20020049498 A1 US20020049498 A1 US 20020049498A1 US 09983537 US09983537 US 09983537 US 98353701 A US98353701 A US 98353701A US 2002049498 A1 US2002049498 A1 US 2002049498A1
Authority
US
Grant status
Application
Patent type
Prior art keywords
disc
material
vertebral
cavity
pat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09983537
Inventor
K. Yuksel
Steven Walsh
Kirby Black
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cryolife Inc
Original Assignee
Cryolife Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/22Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A61L27/3645Connective tissue
    • A61L27/3654Cartilage, e.g. meniscus
    • A61L27/3658Intervertebral discs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • A61F2002/4445Means for culturing intervertebral disc tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/442Intervertebral or spinal discs, e.g. resilient
    • A61F2002/445Intervertebral disc tissue harvest sites

Abstract

Bioprosthetic devices include an exterior biological tissue member which at least partly defines a cavity, and a proteinaceous biopolymer which fills the cavity, and intercalates and is chemically bound (fixed) to the tissue of the surrounding biological tissue member. In preferred forms, the bioprosthetic device is a bioprosthetic vertebral disc having a fibrillar outer annulus which surrounds and defines an interior cavity and is formed by removal of at least a substantial portion of the natural gelatinous core therefrom. The cavity defined by the fibrillar outer annulus may then be filled with a flowable proteinaceous biopolymer. Preferably, the proteinaceous biopolymer is a liquid mixture comprised of human or animal-derived protein material and a di- or polyaldehyde, which are allowed to react in situ to form a cross-linked biopolymer within the cavity. The liquid mixture may be formed in advance of being introduced into the cavity, or may be formed simultaneously during introduction into the cavity.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • [0001]
    The present application is based on, and claims domestic priority benefits under 35 USC §119(e) from, copending U.S. Provisional Application Ser. No. 60/242,457 filed on Oct. 24, 2000, the entire content of which is expressly incorporated hereinto by reference.
  • FIELD OF THE INVENTION
  • [0002]
    The present invention relates generally to bioprosthetics. In especially preferred embodiments, the present invention is related to bioprosthetics formed in situ.
  • BACKGROUND AND SUMMARY OF THE INVENTION
  • [0003]
    The vertebral disc is a collagenous spacer positioned between the vertebral bones of the spinal column. The disc generically consists of a tough fibrillar outer annulus (annulus fibrosus) and a highly hydrated gelatinous core (nucleus pulposus). The vertebral disc serves as a shock absorber to dissipate the energy of impact loading on the back, as well as a joint, allowing flexion and extension of the human torso.
  • [0004]
    Degeneration of vertebral disc function in the lumbar portion of the spine is the leading cause of debilitating low back pain in adults over the age of 35. Degenerative disc disease (DDD) is characterized by a gradual collapse of the vertebral disc due to dehydration of the nucleus pulposus, or by a bulging of the annulus fibrosus. DDD may also precipitate the formation of fissures within the annulus that allows extrusion of the disc nucleus (disc herniation) resulting in a sudden collapse in the disc height and the potential for nerve root and/or spinal cord compression. Disc herniation may also result due to trauma related over compression of the spine, such as a heavy sitting fall.
  • [0005]
    Chronic diffuse low back pain results from irritation of pain receptors in the outer third of the disc annulus and surrounding soft tissues as the disc collapses. Radicular pain results from direct compression of the affected nerve root by extruded or bulging disc tissue. Aggressive and extensive physical therapy and drug treatments are the first line treatments for debilitating back pain. In the absence of acceptable pain resolution, surgical intervention is indicated.
  • [0006]
    The traditional surgical procedures for treatment of intractable low back pain due to DDD call for either fusion of the vertebral bodies above and below the affected disc, or removal of the nuclear material thorough open surgical, micro-surgical or endoscopic procedures. Recently, novel procedures involving thermal shrinkage of the collagenous lamina with an electrothermal catheter or laser device have been applied. The removal of the nucleus leaves a void within the disc, and eliminates the viscoelastic fluid that acts as a shock absorber. This void and absence of the viscoelastic fluid creates an opportunity for the lamina to collapse inward and allows the disc space to collapse further. The collapse of the disc space can lead to loss of motion and morbidity, as during the collapse of the disc space the nerves radiating from the spinal column may be pinched.
  • [0007]
    Many surgical techniques and specialized devices have been generated to combat the problem of progressive disc collapse resulting from disc denucleation. Harvested autologous bone has been placed within the denucleated disc space to afford a bony bridge or fusion between the two vertebral bodies. Pedicle screws and other spinal instruments, such as rods and plates, are mechanically affixed to the vertebral bodies, stabilizing the vertebra and preventing further collapse. The problem with these, and other fusion techniques, is the prevention of motion at the level of repair, and resultant transfer of stresses to the levels above and below. These additional loading stresses inevitably result in the degeneration of these disc levels as well.
  • [0008]
    The patent literature discloses several apparati for the replacement of an entire disc (i.e., prosthetic vertebral disc), whereby the damaged disc is removed and a device is anchored to the vertebral bone below and above the damaged disc. The ultimate goal of such a design concept is to maintain or regain the mobility of the native vertebra-disc-vertebra motion segment. Varying degrees of mobility have been claimed for different types of mechanical disc replacements. The following is a non-exhaustive list of such U.S. Patent disclosures:1 U.S. Pat. No. 4,309,777 to Patil; U.S. Pat. No. 5,865,845 to Thalgott; U.S. Pat. No. 5,827,328 to Buttermann; U.S. Pat. No. 5,865,846 to Bryan et al; U.S. Pat. No. 4,759,766 to Buettner-Jantz et al.; U.S. Pat. No. 5,071,437 to Steffe; U.S. Pat. No. 4,911,718 to Lee et al.; and U.S. Pat. No. 4,714,469 to Kenna. The utility of these prior design proposals has been principally limited by an inability to adequately anchor the flexible prosthetic disc to the bony vertebra.
  • [0009]
    An alternate approach to the repair of damaged or diseased vertebral discs is to physically prevent disc collapse through the insertion of a rigid body into the disc space. The insertion of tubular or other hollow devices, that may, in addition, contain openings through their walls to allow bone growth through the device, enable the motion segment to be fused with the vertebral spacing maintained. These open or tubular devices may be constructed of metallic alloys traditional to implantable medical devices (e.g., stainless steel, titanium and titanium alloys), carbon fiber reinforced engineering thermoplastics (e.g., polyetheretherketones), or machined human cortical bone. These devices have been disclosed, for example, in U.S. Pat. No. 4,961,740 to Ray et al; U.S. Pat. No. 5,015,247 to Michelson; U.S. Pat. No. 5,766,253 to Brosnahan; U.S. Pat. No. 5,425,772 to Brantigan; and U.S. Pat. No. 5,814,084 to Grivas et al. While these devices may retain the proper spacing between the vertebra (i.e., the disc height), they are disadvantageous since, as the two vertebrae are fused, motion across the vertebra-disc-vertebra element is eliminated.
  • [0010]
    Another general technique for the preservation of vertebral body separation is to replace the removed disc nuclear tissue with non-fusing, non-rigid materials. One prior proposal suggests using a bladder that can be filled with liquid to restore disc height (see, U.S. Pat. No. 3,875,595 to Froning). One other prior proposal is disclosed in U.S. Pat. No. 5,534,028 to Bao et al, where a pre-cast pre-shaped hydrogel in placed into the void. Variations on the type of device disclosed in Bao et al '028 are likewise disclosed in U.S. Pat. No. 5,976,186, U.S. Pat. No. 5,192,326, and U.S. Pat. No. 5,047,055. Preformed inserts made from a xerogel plastic as a nucleus pulposus replacement have also been disclosed in U.S. Pat. No. 6,264,695. A cylindrical hydrogel pillow that is contained within a non-expanding casing and assorted variations thereof are described in U.S. Pat. No. 4,772,287, U.S. Pat. No. 4,904,260, U.S. Pat. No. 5,674,295, U.S. Pat. No. 5,824,093, and U.S. Pat. No. 6,022,376. In this regard, the device shown in U.S. Pat. No. 6,022,376 is inserted into tunnels drilled into the disc as a dehydrated hydrogel resin, and is allowed to rehydrate and swell once it is inserted. The swelling holds the device in place while preventing the collapse of the denucleated disc. However, the device is neither chemically nor mechanically fixated in place.
  • [0011]
    It has also been disclosed in U.S. Pat. No. 6,183,581, 6,206,921 and 6,264,659, that molten gutta percha and its compounds may be used as possible replacements of nucleus pulposus.
  • [0012]
    Broadly, the present invention relates to bioprosthetic devices comprised of an exterior biological tissue member which at least partly defines a cavity, and a proteinaceous biopolymer which fills the cavity, and intercalates is chemically bound (linked) to the surrounding biological tissue member. In preferred forms, the bioprosthetic device is a bioprosthetic vertebral disc having a fibrillar outer annulus which surrounds and defines an interior cavity and is formed by removal of at least a substantial portion of the natural gelatinous core therefrom. The cavity defined by the fibrillar outer annulus may then be filled with a flowable biopolymeric material which is then allowed to at least partly solidify in situ (e.g., most preferably by in situ cross-linkage reaction) to form a proteinaceous biopolymer within the cavity.
  • [0013]
    The flowable biopolymeric material is most preferably a liquid mixture liquid mixture comprised of human or animal-derived protein material and a di- or polyaldehyde. When introduced into the cavity of the tissue member, therefore, the liquid mixture may then react to form a cross-linked biopolymer in situ within the cavity thereby forming a bioprosthetic device therein. The liquid mixture may be formed in advance of being introduced into the cavity, or may be formed simultaneously during introduction into the cavity.
  • [0014]
    These and other aspects and advantages will become more apparent after careful consideration is given to the following detailed description of the preferred exemplary embodiments thereof.
  • BRIEF DESCRIPTION OF THE ACCOMPANYING DRAWINGS
  • [0015]
    Reference will hereinafter be made to the accompanying drawing FIGURE which schematically depicts a portion of a patient's vertebral column showing a vertebral disc bioprosthetic in accordance with the present invention interposed between adjacent vertebrae.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0016]
    As used herein and in the accompanying claims, the term “bioprosthetic device” and like terms mean a combination comprised of a biological tissue member and a proteinaceous biopolymer which is chemically bound (linked) to the tissue of the tissue member.
  • [0017]
    The accompanying drawing FIGURE shows a segment of a patient's vertebral column VC wherein vertebral disc bioprosthetics 10 in accordance with the present invention are interposed between adjacent ones of the individual vertebrae V. The vertebral disc bioprosthetics 10 essentially include the fibrillar outer annulus 10-1 of the patient's natural vertebral disc following removal of the gelatinous core. The fibrillar outer annulus 10-1 thus bounds and defines an inner cavity into which a proteinaceous biopolymer 10-2 is injected in situ. The proteinaceous biopolymer (usually referred to hereinafter more simply as the “biopolymer”) 10-2 thus fills completely the void space left following removal of the natural gelatinous core of the patient's natural vertebral disc. The biopolymer 10-2 thus acts as a shock-absorber of sorts similar to the natural functions attributable to the removed gelatinous core.
  • [0018]
    Virtually any suitable proteinaceous biopolymer may be employed in the practice of the present invention. In this regard, the term “proteinaceous biopolymer” and like terms mean a polymeric or copolymeric material which contains one or more units in the polymer chain comprised of natural, synthetic or sequence-modified proteins or polypeptides, and mixtures and blends of such polymeric and/or copolymeric materials.
  • [0019]
    One especially preferred biopolymer 10-2 that may be employed in the practice of this invention is a cross-linked reaction product of a two part mixture initially comprised of:
  • [0020]
    Part A: a water-soluble proteinaceous material of about 27-53% by weight of the mixture, and
  • [0021]
    Part B: di- or polyaldehydes present in a weight ratio of one part by weight to every 20-60 parts of protein present by weight in the mixture and water, optionally containing non-essential ingredients to make up the balance of the composition.
  • [0022]
    Part A of the mixture is most preferably substantially an aqueous solution of a proteinaceous material of human or animal origin. Albumins including ovalbumins are preferred proteins, and serum albumins of human or animal origin are particularly preferred. The proteinaceous material may be a purified protein or a mixture in which the proteins such as serum albumins are the predominant ingredients. For example, the solid mixtures obtained by dehydration of blood plasma or serum, or of commercial solutions of stabilized plasma proteins, can be used to prepare Part A. These mixtures, generally referred to as plasma solids or serum solids, are known to contain albumins as their major ingredients, of the order of 50-90%. As used herein, the term “plasma” refers to whole blood from which the corpuscles have been removed by centrifugation. The term “serum” refers to plasma which has additionally been treated to prevent agglutination by removal of its fibrinogen and/or fibrin, or by inhibiting the fibrin clot formation through addition of reagents, such as citrate or EDTA. The proteinaceous material may also contain an effective amount of hemoglobin.
  • [0023]
    Part B is substantially an aqueous solution of di- or polyaldehydes. A wide range of these substances exist, and their usefulness is restricted largely by availability and by their solubility in water. For example, aqueous glyoxal (ethandial) is useful, as is aqueous glutaraldehyde (pentandial). Water soluble mixtures of di- and polyaldehydes prepared by oxidative cleavage of appropriate carbohydrates with periodate, ozone or the like are also useful. Glutaraldehyde is the preferred dialdehyde ingredient of Part B. When Parts A and B are brought together, the resultant product rapidly hardens to a strong, flexible, leathery or rubbery material within a short time of mixing, generally on the order of 15-30 seconds. The most preferred material for use in the present invention is commercially available from CryoLife, Inc. of Kennesaw, Ga. under the registered trademark “BIOGLUE”. (See also, U.S. Pat. No. 5,385,606, the entire content of which is expressly incorporated hereinto by reference.)
  • [0024]
    The two components A and B noted above are either premixed and then applied, or simultaneously mixed and delivered through an in-line mixing/dispensing tip during the filling of the tissue-defined cavity. Upon reaction of the two components, the resulting biomaterial is a hydrogel that adheres to the surrounding tissue, intercalates into the voids of the surrounding tissues, is space filling, and is mechanically and biologically stable for some time. The material may be solid or sponge-like in appearance. Furthermore, it may contain organic or inorganic salts or other particulate matter to modify the physical properties of the resulting bioprosthetic device. Preferably, the biopolymer 10-2 will exhibit compressive strengths of at least 300 kPa (preferably between about 300 to about 600 kPa) and compressive moduli of 2.5 MPa, and creep moduli of 1.0 MPa. The ultimate compressive strength of the biopolymer 10-2 can be adjusted by altering the composition of the protein and cross-linker components and/or through the addition of various fillers.
  • [0025]
    As noted previously, the proteinaceous biopolymer that may be employed in the practice of the present invention may be include as on reactable component a natural, synthetic or sequence-modified (i.e., so-called “engineered”) polypeptides (e.g., as disclosed more fully in U.S. Pat. No. 6,018,030; U.S. Pat. No. 5,374,431; U.S. Pat. No. 5,606,019 or U.S. Pat. No. 5,817,303, incorporated fully by reference herein). Thus, although many of the following examples employ albumin, it will be understood by those in this art that other reactable components may be employed satisfactorily. Reactable synthetic polymeric components, namely, those which contain functional groups to cause cross-linking (e.g. polyethylene-glycol polymers derivatized with electrophilic and nucleophilic groups such as amine, succinimidyl, anhydride, thiol) may also be employed in the practice of the present invention. See in this regard, U.S. Pat. No. 6,166,130; U.S. Pat. No. 6,051,648; or U.S. Pat. No. 5,900,245, the entirety of each being expressly incorporated hereinto by reference.
  • [0026]
    Nominal compressive mechanical properties that are obtained are similar to those of vertebral discs and lumbar vertebra. The compressive properties of the described biomaterial 10-2 are very different from highly rigid materials traditionally used as implantable structural elements such as stainless steel, titanium, polyacrylate bone cements, ceramics or carbon fiber composites, and hence allow for better biomechanical compatibility in selected indications. For example, the bioprosthetic vertebral discs of the present invention exhibit flexibility comparable to the biologically natural vertebral disc. More specifically, the bioprosthetic vertebral discs of the present invention exhibit flexibility comparable to the biologically natural vertebral disc after being subjected to at least about 5 million cycles of a cyclic load of about 0.85 MPa
  • [0027]
    The particular properties of the biopolymer 10-2 can be “engineered” to suit specific end uses. For example, the biopolymer may include fibrous or particulate reinforcement (“filler”) material, provided it is biocompatible.
  • [0028]
    Thus, natural or synthetic fibers, such as polyesters, nylons, polyolefins, glass and the like of virtually any desired denier may be employed. Furthermore, the reinforcing fibers may be used in the form of a continuous length of single fibers (i.e., monofilaments) or a yarn, roving or rope of multiple filaments. Moreover, the reinforcing media may be in the form of staple fibers of predetermined lengths which are spun into yarns, rovings and/or ropes of desired denier and continuous length. The mono- or multifilamentary reinforcing materials may also be in the form of woven or non-woven fabric structures. Suffice it to say here, that virtually any physical form of fibrous reinforcing material may be satisfactorily employed in the practice of the present invention.
  • [0029]
    The reinforcing material may also be in the form of particulates, such as synthetic or natural organic and inorganic particulate reinforcement materials. Some representative examples of such particulates include calcium carbonate, calcium phosphate, hydroxyapatite bone chips, ceramic particles and the like.
  • [0030]
    The present invention will be further described with reference to the following non-limiting Examples.
  • EXAMPLES Example 1
  • [0031]
    A formulation formed of a protein solution (serum albumin) and a cross linker (gluteraldehyde) was contained in the separate chambers of a delivery device. When the device is triggered, the two components are expelled from their respective chambers into a mixing tip that combines the two solutions and mixes them as they travel over the static mixing elements present in the tip. A medical needle was attached to the mixing tip and the formulation injected into the distal space between the vertebra of an explanted pig spine. The tip can be attached to a needle, catheter, or other hollow tubular device for delivery, for example. After 30 seconds, the needle was withdrawn from the injection site. The material that was injected had polymerized in place and did not exude out of the needle hole. After 2 minutes, the disc-vertebra plate was dissected and the presence of the biomaterial seen.
  • Example 2
  • [0032]
    Bovine calf spines were obtained from a commercial slaughterhouse and cleaned by blunt and sharp dissection to expose the vertebral bodies and the discs. A 4 mm hole was made into the anterior face of the disc and the drill bit allowed to enter to the center of the nucleus. The nuclear material was removed using surgical forceps and curettes. The hollow space was filled with the formulation described in Example 1. The material that was injected polymerized in place and did not exude out of the hole. After 2 minutes the disc-vertebra plate was dissected and the presence of the biomaterial seen.
  • Example 3
  • [0033]
    Bovine calf spines were obtained from a commercial slaughterhouse and cleaned by blunt and sharp dissection to expose the vertebral bodies and the discs. The top and bottom of the vertebral bodies were cut parallel to each other at mid-height using a miter box to yield a bone/disc/bone motion segment. A 4 mm hole was made into the anterior face of the disc and the drill bit allowed to enter into the center of the nucleus. The nuclear material was removed using surgical forceps and curettes. The hollow space was filled with the formulation described in Example 1. The material that was injected had polymerized in place and did not exude out of the hole.
  • [0034]
    Once polymerization had occurred, the construct could be compressed by hand in the front-back and left-right axes, indicating flexibility was retained after repair of this segment. Then, the construct was placed in a biomaterials testing device (Instron electromechanical test station) and compressed repeatedly to a load of 700 N to condition the construct. Thereafter, a constant load of 700 N was applied to measure compressive creep. The load was held for 10 min. During this time, the polymerized material did not exit from the distal space or the hole. A force of 700 N is the published literature value for the load a lumbar spinal disc experiences when a person of average built is standing upright. The experiment was repeated on 5 separate samples.
  • [0035]
    In this example, the motion segment height was measured before removal of the nucleus, after removal of the nucleus, after filling with the biomaterial, and after loading and releasing the load. It was found that (1) the removal of the nucleus reduced the overall height of the material, as well as the compressibility, (2) the filling with the biomaterial restored the disc height and the compressibility.
  • Example 4
  • [0036]
    A disc of biomaterial formed by injecting a volume of material with the formulation described in Example 1 into a cavity mold was compressed for 100 and 1000 cycles at a compression rate of 100 mm/min between a minimum stress of 200 kPa and a maximum stress of either 470 or 800 kPa (equivalent to a normal lumbar disc, cross sectional area of 1500 mm2, loaded between 300 N and 700 or 1200 N). The disc element did not exhibit fracture, permanent deformation, or demonstrate a loss of hydration (by mass loss analysis). A force of 1200 N is the published literature value for the compressive load a lumbar spinal disc experiences when a person of average built flexes forward.
  • Example 5
  • [0037]
    Bovine calf spines were obtained and prepared as described in Example 3. In this example, the nucleus pulposus was accessed either from an anterior or a posterolateral direction. The constructs were then placed under a cyclic load of 0.85 MPa at 5 Hz and the load applied for >5 million cycles. During this time, the constructs were kept in physiological saline solution containing a non-fixative biocidal agent. At the end of the test period, the constructs were removed and the disc sliced parallel to the end plates to observe the status of the implants. The implant present in the cavity created by the removal of the nucleus pulposus, was intact and flexible.
  • Example 6
  • [0038]
    Samples of the biomaterial were formed as described in Example 4. The biomaterial was then placed under a cyclic load of 0.5 MPa at approximately 2 Hz and the load applied for either >5 million cycles or >10 million cycles. During this time, the constructs were kept in physiological saline solution containing a non-fixative biocidal agent. The test samples remained intact throughout the duration of the test, and demonstrated <10% loss in original height.
  • [0039]
    While the invention has been described in connection with what is presently considered to be the most practical and preferred embodiment, it is to be understood that the invention is not to be limited to the disclosed embodiment, but on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.

Claims (42)

    What is claimed is:
  1. 1. The combination comprised of an exterior biological tissue member which at least partly defines a cavity, and a polymeric material which fills the cavity, intercalates the surrounding biological tissue member, and is chemically bound to the tissue of the surrounding biological tissue member.
  2. 2. The combination of claim 1, wherein the polymeric material is a proteinaceous biopolymer.
  3. 3. The combination of claim 1, wherein the polymeric material includes a fibrous or particulate filler material.
  4. 4. The combination of claim 2, wherein the biopolymer is the cross-linked reaction product of human or animal-derived protein material and a di- or polyaldehyde.
  5. 5. The combination of claim 4, wherein the protein is bovine or human serum albumin or hemoglobin.
  6. 6. The combination of claim 5, wherein the aldehyde is glutaraldehyde.
  7. 7. The combination of any one of claims 1-6, in the form of a vertebral disc.
  8. 8. The combination of claim 7, wherein the vertebral disc which remains intact and flexible after being subjected to 5 million cycles of a cyclic load of 0.85 MPa.
  9. 9. The combination of claim 2, wherein the proteinaceous biopolymer is the reaction product of at least two reactable components, and wherein one of the components includes a natural, synthetic or sequence-modified polypeptide.
  10. 10. The combination of claim 1, wherein the polymeric material is the reaction product of at least two reactable components, and wherein one of the components includes a synthetic polymeric component which contains a cross-linkable functional group.
  11. 11. The combination of claim 10, wherein the synthetic polymeric components includes polyethylene glycol polymer derivatized with electrophilic and/or nucleophilic groups.
  12. 12. The combination of claim 11, wherein the electrophilic and/or nucleophilic groups include at least one selected from amine, succinimidyl, anhydride and thiol groups.
  13. 13. A bioprosthetic vertebral disc comprised of a fibrillar outer annulus which remains following removal of a gelatinous core from a biologically natural vertebral disc to thereby define an interior cavity, and a proteinaceous biopolymer which fills the cavity and intercalates the surrounding biological tissue of the fibrillar outer annulus.
  14. 14. The bioprosthetic vertebral disc of claim 13, that exhibits flexibility comparable to the biologically natural vertebral disc.
  15. 15. The bioprosthetic vertebral disc of claim 14, that exhibits flexibility comparable to the biologically natural vertebral disc after being subjected to 5 million cycles of a cyclic load of 0.85 MPa.
  16. 16. The bioprosthetic vertebral disc of claim 14, wherein the biopolymer includes a fibrous or particulate filler material.
  17. 17. The bioprosthetic vertebral disc of claim 13, wherein the biopolymer is the cross-linked reaction product of human or animal-derived protein material and a di- or polyaldehyde.
  18. 18. The bioprosthetic vertebral disc of claim 17, wherein the protein is bovine or human serum albumin or hemoglobin.
  19. 19. The bioprosthetic vertebral disc of claim 17 or 18, wherein the aldehyde is glutaraldehyde.
  20. 20. A method for the in situ formation of a bioprosthetic device comprising filling a cavity defined at least partly by surrounding biological tissue material with a flowable polymeric material in situ within the cavity thereby forming the bioprosthetic device.
  21. 21. The method of claim 20, which comprises injecting a flowable proteinaceous biopolymer into the cavity, and allowing the proteinaceous biopolymer to at least partly solidify in situ therewithin.
  22. 22. The method of claim 20, said method comprises injecting at least two reactable biopolymeric components in situ within the cavity, and allowing the reactable biopolymeric components at least partly solidify by a cross-linkage reaction therebetween.
  23. 23. The method of claim 21, wherein said at least two reactable components are premixed before being injected into the cavity.
  24. 24. The method of claim 21, wherein said at least two reactable components are mixed simultaneously while being injected into the cavity.
  25. 25. The method of claim 21, wherein said at least two reactable components include a liquid mixture comprised of human or animal-derived protein material and a di- or polyaldehyde, and wherein the method comprises allowing the liquid mixture to form a cross-linked proteinaceous biopolymer material in situ within the cavity.
  26. 26. The method of claim 25, wherein said protein material and said di- or polyaldehyde are premixed before being introduced into the cavity.
  27. 27. The method of claim 25, wherein said protein material and said di- or polyaldehyde are mixed simultaneously while being introduced into the cavity.
  28. 28. The method of claim 25, which includes providing a fibrous or particulate filler material in the liquid mixture.
  29. 29. The method of claim 21, wherein the proteinaceous biopolymer is the reaction product of at least two reactable components, and wherein one of the components includes a natural, synthetic or sequence-modified polypeptide.
  30. 30. The method of claim 20, wherein the polymeric material is the reaction product of at least two reactable components, and wherein one of the components includes a synthetic polymeric component which contains a cross-linkable functional group.
  31. 31. The method of claim 30, wherein the at least one of the reactable components includes polyethylene glycol polymer derivatized with electrophilic and/or nucleophilic groups.
  32. 32. The method of claim 31, wherein the electrophilic and/or nucleophilic groups include at least one selected from amine, succinimidyl, anhydride and thiol groups.
  33. 33. A method for the formation of a bioprosthetic vertebral disc comprising:
    (a) providing a vertebral disc having a fibrillar outer annulus which surrounds and defines an interior cavity formed by removal of at least a substantial portion of a gelatinous core therefrom;
    (b) filling the cavity defined by the fibrillar outer annulus with a flowable polymeric material, and
    (c) allowing the polymeric material to at least partly solidify in situ within the cavity.
  34. 34. The method of claim 33, wherein the polymeric material is a proteinaceous biopolymer.
  35. 35. The method of claim 33, said method comprises injecting at least two reactable biopolymeric components in situ within the cavity, and allowing the reactable biopolymeric components at least partly solidify by reaction therebetween.
  36. 36. The method of claim 35, wherein said at least two reactable components are premixed before being injected into the cavity.
  37. 37. The method of claim 35, wherein said at least two reactable components are mixed simultaneously while being injected into the cavity.
  38. 38. The method of claim 35, wherein said at least two reactable components include a liquid mixture comprised of human or animal-derived protein material and a di- or polyaldehyde, and wherein the method comprises allowing the liquid mixture to form a cross-linked proteinaceous biopolymer material in situ within the cavity.
  39. 39. The method of claim 38, wherein said protein material and said di- or polyaldehyde are premixed before being introduced into the cavity.
  40. 40. The method of claim 38, wherein said protein material and said di- or polyaldehyde are mixed simultaneously while being introduced into the cavity.
  41. 41. The method of claim 38, which includes providing a fibrous or particulate filler material in the liquid mixture.
  42. 42. The method of claim 33, wherein prior to step (a) there is practiced the step of (a1) removing a substantial portion of the gelatinous core of the vertebral disc to leave the fibrillar outer annulus which defines the interior cavity.
US09983537 2000-10-24 2001-10-24 In situ bioprosthetic filler and methods, particularly for the in situ formation of vertebral disc bioprosthetics Abandoned US20020049498A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US24245700 true 2000-10-24 2000-10-24
US09983537 US20020049498A1 (en) 2000-10-24 2001-10-24 In situ bioprosthetic filler and methods, particularly for the in situ formation of vertebral disc bioprosthetics

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09983537 US20020049498A1 (en) 2000-10-24 2001-10-24 In situ bioprosthetic filler and methods, particularly for the in situ formation of vertebral disc bioprosthetics
US11008609 US7621959B2 (en) 2000-10-24 2004-12-10 Methods for the in situ formation of a bioprosthetic device, particularly vertebral disc bioprosthetics
US11635928 US7621954B2 (en) 2000-10-24 2006-12-08 In situ bioprosthetic filler and methods, particularly for in situ formation of vertebral disc bioprosthetics
US11932066 US7896920B2 (en) 2000-10-24 2007-10-31 In situ bioprosthetic filler and method, particularly for the in situ formation of vertebral disc bioprosthetics

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11008609 Division US7621959B2 (en) 2000-10-24 2004-12-10 Methods for the in situ formation of a bioprosthetic device, particularly vertebral disc bioprosthetics

Publications (1)

Publication Number Publication Date
US20020049498A1 true true US20020049498A1 (en) 2002-04-25

Family

ID=22914850

Family Applications (4)

Application Number Title Priority Date Filing Date
US09983537 Abandoned US20020049498A1 (en) 2000-10-24 2001-10-24 In situ bioprosthetic filler and methods, particularly for the in situ formation of vertebral disc bioprosthetics
US11008609 Expired - Fee Related US7621959B2 (en) 2000-10-24 2004-12-10 Methods for the in situ formation of a bioprosthetic device, particularly vertebral disc bioprosthetics
US11635928 Expired - Fee Related US7621954B2 (en) 2000-10-24 2006-12-08 In situ bioprosthetic filler and methods, particularly for in situ formation of vertebral disc bioprosthetics
US11932066 Active 2022-03-17 US7896920B2 (en) 2000-10-24 2007-10-31 In situ bioprosthetic filler and method, particularly for the in situ formation of vertebral disc bioprosthetics

Family Applications After (3)

Application Number Title Priority Date Filing Date
US11008609 Expired - Fee Related US7621959B2 (en) 2000-10-24 2004-12-10 Methods for the in situ formation of a bioprosthetic device, particularly vertebral disc bioprosthetics
US11635928 Expired - Fee Related US7621954B2 (en) 2000-10-24 2006-12-08 In situ bioprosthetic filler and methods, particularly for in situ formation of vertebral disc bioprosthetics
US11932066 Active 2022-03-17 US7896920B2 (en) 2000-10-24 2007-10-31 In situ bioprosthetic filler and method, particularly for the in situ formation of vertebral disc bioprosthetics

Country Status (7)

Country Link
US (4) US20020049498A1 (en)
EP (1) EP1328220B1 (en)
JP (1) JP4202749B2 (en)
CA (1) CA2422884C (en)
DE (1) DE60143804D1 (en)
ES (1) ES2358498T3 (en)
WO (1) WO2002034111A3 (en)

Cited By (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020151979A1 (en) * 1999-08-18 2002-10-17 Lambrecht Greg H. Devices and method for nucleus pulposus augmentation and retention
US20030009227A1 (en) * 1999-08-18 2003-01-09 Lambrecht Gregory H. Methods of reinforcing an annulus fibrosis
US20030153927A1 (en) * 2001-05-15 2003-08-14 Endius Incorporated Structure for receiving surgical instruments
US20030181365A1 (en) * 2002-03-19 2003-09-25 Slivka Michael Andrew Method for nonsurgical treatment of the intervertebral disc and kit therefor
US20030220691A1 (en) * 2002-05-23 2003-11-27 Pioneer Laboratories, Inc. Artificial intervertebral disc device
US20040024465A1 (en) * 1999-08-18 2004-02-05 Gregory Lambrecht Devices and method for augmenting a vertebral disc
US20040044412A1 (en) * 1999-08-18 2004-03-04 Gregory Lambrecht Devices and method for augmenting a vertebral disc
WO2004028414A1 (en) 2002-09-25 2004-04-08 Medicinelodge, Inc. Apparatus and method for the in-situ formation of a structural prosthesis
US20040133229A1 (en) * 2000-08-18 2004-07-08 Lambrecht Gregory H. Minimally invasive system for manipulating intervertebral disc tissue
US20040186471A1 (en) * 2002-12-07 2004-09-23 Sdgi Holdings, Inc. Method and apparatus for intervertebral disc expansion
US20040230305A1 (en) * 2002-09-24 2004-11-18 Bogomir Gorensek Stabilizing device for intervertebral disc, and methods thereof
US20040228901A1 (en) * 2002-09-18 2004-11-18 Trieu Hai H. Collagen-based materials and methods for treating synovial joints
US20040260300A1 (en) * 2003-06-20 2004-12-23 Bogomir Gorensek Method of delivering an implant through an annular defect in an intervertebral disc
US20040260305A1 (en) * 2003-06-20 2004-12-23 Bogomir Gorensek Device for delivering an implant through an annular defect in an intervertebral disc
US20050002909A1 (en) * 2000-04-07 2005-01-06 Centerpulse Biologics Inc Methods and compositions for treating intervertebral disc degeneration
US20050004578A1 (en) * 1999-08-18 2005-01-06 Lambrecht Gregory H. Apparatus delivery in an intervertebral disc
US20050071012A1 (en) * 2003-09-30 2005-03-31 Hassan Serhan Methods and devices to replace spinal disc nucleus pulposus
US20050116400A1 (en) * 2003-11-14 2005-06-02 White Moreno J. Non-linear fiber/matrix architecture
US20050119754A1 (en) * 2002-09-18 2005-06-02 Trieu Hai H. Compositions and methods for treating intervertebral discs with collagen-based materials
US20050182414A1 (en) * 2004-01-08 2005-08-18 Richard Manzi Apparatus and method for injecting fluent material at a distracted tissue site
US20050192671A1 (en) * 2002-05-23 2005-09-01 Pioneer Laboratories, Inc. Artificial disc device
US20050209699A1 (en) * 2002-03-19 2005-09-22 Slivka Michael A Method for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor
US20050234557A1 (en) * 1999-08-18 2005-10-20 Lambrecht Gregory H Stabilized intervertebral disc barrier
US20060188487A1 (en) * 2005-02-23 2006-08-24 Zimmer Technology, Inc. Blend hydrogels and methods of making
US20060287727A1 (en) * 2005-06-15 2006-12-21 Jerome Segal Mechanical apparatus and method for artificial disc replacement
US20070003525A1 (en) * 2003-01-31 2007-01-04 Moehlenbruck Jeffrey W Hydrogel compositions comprising nucleus pulposus tissue
US20070100349A1 (en) * 2005-10-27 2007-05-03 O'neil Michael Nucleus augmentation delivery device and technique
US20070134343A1 (en) * 2002-11-15 2007-06-14 Trieu Hai H Collagen-based materials and methods for treating synovial joints
US20070134333A1 (en) * 2005-12-07 2007-06-14 Zimmer, Inc. Methods of bonding or modifying hydrogels using irradiation
US20070173943A1 (en) * 2003-01-17 2007-07-26 Dulak Gary R Artificial nucleus pulposus and method of injecting same
US20070203579A1 (en) * 2006-02-27 2007-08-30 Sdgi Holdings, Inc. Prosthetic device for spinal arthroplasty
US20070233245A1 (en) * 2006-03-31 2007-10-04 Sdgi Holdings, Inc. Methods and instruments for delivering intervertebral devices
US20070255406A1 (en) * 2006-04-27 2007-11-01 Sdgi Holdings, Inc. Devices, apparatus, and methods for bilateral approach to disc augmentation
US20070255286A1 (en) * 2006-04-27 2007-11-01 Sdgi Holdings, Inc. Devices, apparatus, and methods for improved disc augmentation
US20080004570A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic, Inc. Collagen delivery device
US20080004431A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic Inc Method of manufacturing an injectable collagen material
US20080004214A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic, Inc Injectable collagen material
US20080004703A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic, Inc. Method of treating a patient using a collagen material
US20080033575A1 (en) * 2006-08-04 2008-02-07 Christopher Walsh Reversibly deformable implant
US20080268056A1 (en) * 2007-04-26 2008-10-30 Abhijeet Joshi Injectable copolymer hydrogel useful for repairing vertebral compression fractures
US20080269897A1 (en) * 2007-04-26 2008-10-30 Abhijeet Joshi Implantable device and methods for repairing articulating joints for using the same
US20090093852A1 (en) * 2007-10-05 2009-04-09 Hynes Richard A Spinal stabilization treatment methods for maintaining axial spine height and sagital plane spine balance
US20090222096A1 (en) * 2008-02-28 2009-09-03 Warsaw Orthopedic, Inc. Multi-compartment expandable devices and methods for intervertebral disc expansion and augmentation
US20090297603A1 (en) * 2008-05-29 2009-12-03 Abhijeet Joshi Interspinous dynamic stabilization system with anisotropic hydrogels
US7655012B2 (en) 2003-10-02 2010-02-02 Zimmer Spine, Inc. Methods and apparatuses for minimally invasive replacement of intervertebral discs
US7731988B2 (en) 2007-08-03 2010-06-08 Zimmer, Inc. Multi-polymer hydrogels
US7753941B2 (en) 2000-04-04 2010-07-13 Anulex Technologies, Inc. Devices and methods for annular repair of intervertebral discs
US20100184223A1 (en) * 2007-07-13 2010-07-22 Helmut Wurst Biomaterial based on a hydrophilic polymeric carrier
US20100322993A1 (en) * 2008-01-28 2010-12-23 Nmi Naturwissenschaftliches Und Medizinisches Institut An Der Universitaet Tuebingen Injectable biocompatible composition
US7947784B2 (en) 2007-11-16 2011-05-24 Zimmer, Inc. Reactive compounding of hydrogels
US7959679B2 (en) 1999-08-18 2011-06-14 Intrinsic Therapeutics, Inc. Intervertebral anulus and nucleus augmentation
US7972337B2 (en) 2005-12-28 2011-07-05 Intrinsic Therapeutics, Inc. Devices and methods for bone anchoring
US7985781B2 (en) 2004-10-12 2011-07-26 Zimmer Gmbh PVA hydrogel
US8017107B2 (en) 2005-12-22 2011-09-13 Zimmer, Inc. Perfluorocyclobutane crosslinked hydrogels
US8034362B2 (en) 2008-01-04 2011-10-11 Zimmer, Inc. Chemical composition of hydrogels for use as articulating surfaces
US20110270393A1 (en) * 2008-06-04 2011-11-03 James Marvel Buffer for a human joint and method of arthroscopically inserting
US8062739B2 (en) 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US8110242B2 (en) 2006-03-24 2012-02-07 Zimmer, Inc. Methods of preparing hydrogel coatings
US8133279B2 (en) 2006-04-27 2012-03-13 Warsaw Orthopedic, Inc. Methods for treating an annulus defect of an intervertebral disc
US8231678B2 (en) 1999-08-18 2012-07-31 Intrinsic Therapeutics, Inc. Method of treating a herniated disc
US8323341B2 (en) 2007-09-07 2012-12-04 Intrinsic Therapeutics, Inc. Impaction grafting for vertebral fusion
US8454612B2 (en) 2007-09-07 2013-06-04 Intrinsic Therapeutics, Inc. Method for vertebral endplate reconstruction
US8518049B2 (en) 2006-07-27 2013-08-27 Lanx, Inc. Methods and apparatuses for facilitating percutaneous fusion
WO2014074870A1 (en) * 2012-11-08 2014-05-15 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system
US9233011B2 (en) 2006-09-15 2016-01-12 Pioneer Surgical Technology, Inc. Systems and apparatuses for inserting an implant in intervertebral space
US9241807B2 (en) 2011-12-23 2016-01-26 Pioneer Surgical Technology, Inc. Systems and methods for inserting a spinal device
US9445916B2 (en) 2003-10-22 2016-09-20 Pioneer Surgical Technology, Inc. Joint arthroplasty devices having articulating members
US9668875B2 (en) 1999-03-07 2017-06-06 Nuvasive, Inc. Method and apparatus for computerized surgery

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020939A3 (en) 1996-11-15 1998-09-03 Advanced Bio Surfaces Inc Biomaterial system for in situ tissue repair
ES2358498T3 (en) * 2000-10-24 2011-05-11 Cryolife, Inc. Bioprosthetic filling and methods, particularly for the in situ formation of intervertebral discs bioprosthesis.
US7226615B2 (en) * 2000-11-07 2007-06-05 Cryolife, Inc. Expandable foam-like biomaterials and methods
EP1227094B1 (en) * 2001-01-30 2005-12-14 Nissan Chemical Industries Ltd. Isocyanurate compound and method for producing the same
CA2735334A1 (en) * 2002-11-05 2004-05-21 Spineology, Inc. A semi-biological intervertebral disc replacement system
FR2854801B1 (en) * 2003-05-12 2006-09-01 Khorionyx injection of insoluble globin implant
US7789913B2 (en) * 2004-06-29 2010-09-07 Spine Wave, Inc. Methods for injecting a curable biomaterial into an intervertebral space
JP4601051B2 (en) * 2004-12-20 2010-12-22 株式会社セタ Game chips
US7955339B2 (en) * 2005-05-24 2011-06-07 Kyphon Sarl Low-compliance expandable medical device
US20070233244A1 (en) * 2006-03-28 2007-10-04 Depuy Spine, Inc. Artificial Disc Replacement Using Posterior Approach
US8282641B2 (en) 2006-03-28 2012-10-09 Depuy Spine, Inc. Methods and instrumentation for disc replacement
US8137404B2 (en) * 2006-03-28 2012-03-20 Depuy Spine, Inc. Artificial disc replacement using posterior approach
US20070276491A1 (en) * 2006-05-24 2007-11-29 Disc Dynamics, Inc. Mold assembly for intervertebral prosthesis
US8092536B2 (en) * 2006-05-24 2012-01-10 Disc Dynamics, Inc. Retention structure for in situ formation of an intervertebral prosthesis
US8357168B2 (en) * 2006-09-08 2013-01-22 Spine Wave, Inc. Modular injection needle and seal assembly
US8715352B2 (en) * 2006-12-14 2014-05-06 Depuy Spine, Inc. Buckling disc replacement
US8864801B2 (en) * 2007-04-30 2014-10-21 Warsaw Orthopedic, Inc. Method of deformity correction in a spine using injectable materials
NL1035724C2 (en) * 2008-07-18 2010-01-22 Univ Eindhoven Tech A prosthesis comprising a core of a gel material in a woven envelope and a method for making the same and their use.
US9132207B2 (en) 2009-10-27 2015-09-15 Spine Wave, Inc. Radiopaque injectable nucleus hydrogel compositions
CN102740779A (en) * 2010-02-23 2012-10-17 克莱约生命公司 Applicator delivery tip extension
US9358122B2 (en) 2011-01-07 2016-06-07 K2M, Inc. Interbody spacer
WO2012131383A1 (en) 2011-03-31 2012-10-04 Isis Innovation Limited Intervertebral disc treatment apparatus
US20120276008A1 (en) * 2011-04-26 2012-11-01 Spine Wave, Inc. Radiopaque injectable nucleus hydrogel compositions
US20140277467A1 (en) 2013-03-14 2014-09-18 Spinal Stabilization Technologies, Llc Prosthetic Spinal Disk Nucleus
WO2017176973A1 (en) * 2016-04-07 2017-10-12 Rowan University Methods and compositions for inducing multi-targeted healing of intervertebral disc defects

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5766584A (en) * 1995-06-02 1998-06-16 Massachusetts Institute Of Technology Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells
US5824093A (en) * 1994-10-17 1998-10-20 Raymedica, Inc. Prosthetic spinal disc nucleus
US5874500A (en) * 1995-12-18 1999-02-23 Cohesion Technologies, Inc. Crosslinked polymer compositions and methods for their use
US6395032B1 (en) * 1998-12-11 2002-05-28 Dimso (Distribution Medicale Du Sud-Ouest) Intervertebral disc prosthesis with liquid chamber
US6488952B1 (en) * 2001-08-28 2002-12-03 John P. Kennedy Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
US20040091540A1 (en) * 2000-11-15 2004-05-13 Desrosiers Eric Andre Method for restoring a damaged or degenerated intervertebral disc
US20040220296A1 (en) * 2003-04-30 2004-11-04 Lowman Anthony M. Thermogelling polymer blends for biomaterial applications
US6936070B1 (en) * 2001-01-17 2005-08-30 Nabil L. Muhanna Intervertebral disc prosthesis and methods of implantation
US7004945B2 (en) * 2001-11-01 2006-02-28 Spinewave, Inc. Devices and methods for the restoration of a spinal disc
US20060089721A1 (en) * 2001-01-17 2006-04-27 Muhanna Nabil L Intervertebral disc prosthesis and methods of implantation
US20070173943A1 (en) * 2003-01-17 2007-07-26 Dulak Gary R Artificial nucleus pulposus and method of injecting same

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309777A (en) * 1980-11-13 1982-01-12 Patil Arun A Artificial intervertebral disc
US4472840A (en) * 1981-09-21 1984-09-25 Jefferies Steven R Method of inducing osseous formation by implanting bone graft material
US4394370A (en) * 1981-09-21 1983-07-19 Jefferies Steven R Bone graft material for osseous defects and method of making same
EP0164483B1 (en) * 1984-06-12 1989-08-16 Oscobal Ag Method of producing a bone replacement material
US4620327A (en) * 1984-07-05 1986-11-04 Caplan Arnold I Process of adapting soluble bone protein for use in stimulating osteoinduction
EP0176728B1 (en) * 1984-09-04 1989-07-26 Humboldt-Universität zu Berlin Intervertebral-disc prosthesis
US4600533A (en) * 1984-12-24 1986-07-15 Collagen Corporation Collagen membranes for medical use
US6018030A (en) * 1986-11-04 2000-01-25 Protein Polymer Technologies, Inc. Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
US5606019A (en) * 1987-10-29 1997-02-25 Protien Polymer Technologies, Inc. Synthetic protein as implantables
US4714469A (en) * 1987-02-26 1987-12-22 Pfizer Hospital Products Group, Inc. Spinal implant
DE3734923C1 (en) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh A process for the preparation of a sterile plasma protein solution containing fibrinogen and coagulation factor XIII;
CA1339083C (en) * 1987-11-13 1997-07-29 Steven R. Jefferies Bone repair material and delayed drug delivery system
US4911718A (en) * 1988-06-10 1990-03-27 University Of Medicine & Dentistry Of N.J. Functional and biocompatible intervertebral disc spacer
US5213580A (en) * 1988-08-24 1993-05-25 Endoluminal Therapeutics, Inc. Biodegradable polymeric endoluminal sealing process
US5258028A (en) * 1988-12-12 1993-11-02 Ersek Robert A Textured micro implants
CA1318469C (en) * 1989-02-15 1993-06-01 Acromed Corporation Artificial disc
JP2817966B2 (en) 1989-10-13 1998-10-30 旭光学工業株式会社 Hard tissue filling for kneaded with reduced irritation to the living body and a manufacturing method thereof
US5385606A (en) * 1992-07-06 1995-01-31 Kowanko; Nicholas Adhesive composition and method
EP0621020A1 (en) * 1993-04-21 1994-10-26 SULZER Medizinaltechnik AG Intervertebral prosthesis and method of implanting such a prosthesis
US5373431A (en) * 1993-08-31 1994-12-13 Cooper Industries, Inc. Ring/baffle element for a trim of a recessed lighting fixture
US5514180A (en) * 1994-01-14 1996-05-07 Heggeness; Michael H. Prosthetic intervertebral devices
US6140452A (en) * 1994-05-06 2000-10-31 Advanced Bio Surfaces, Inc. Biomaterial for in situ tissue repair
US6187048B1 (en) * 1994-05-24 2001-02-13 Surgical Dynamics, Inc. Intervertebral disc implant
US5674296A (en) * 1994-11-14 1997-10-07 Spinal Dynamics Corporation Human spinal disc prosthesis
US5900245A (en) * 1996-03-22 1999-05-04 Focal, Inc. Compliant tissue sealants
US5817303A (en) * 1995-05-05 1998-10-06 Protein Polymer Technologies, Inc. Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer
US6099565A (en) * 1995-06-07 2000-08-08 Sakura, Jr.; Chester Y. Prosthetic tissue implant and filler therefor
US5865845A (en) * 1996-03-05 1999-02-02 Thalgott; John S. Prosthetic intervertebral disc
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US5895426A (en) * 1996-09-06 1999-04-20 Osteotech, Inc. Fusion implant device and method of use
US5827328A (en) * 1996-11-22 1998-10-27 Buttermann; Glenn R. Intervertebral prosthetic device
US6994686B2 (en) * 1998-08-26 2006-02-07 Neomend, Inc. Systems for applying cross-linked mechanical barriers
JPH1170592A (en) * 1997-03-18 1999-03-16 Bridgestone Corp Antistatic tire and its manufacture
US5800549A (en) * 1997-04-30 1998-09-01 Howmedica Inc. Method and apparatus for injecting an elastic spinal implant
US5906997A (en) * 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6048346A (en) * 1997-08-13 2000-04-11 Kyphon Inc. Systems and methods for injecting flowable materials into bones
JP3695511B2 (en) 1998-07-03 2005-09-14 ニプロ株式会社 Bone regeneration material
KR100563476B1 (en) 1998-07-03 2006-03-27 김홍렬 Bone regeneration material
JP4732587B2 (en) 1999-02-04 2011-07-27 ウォーソー・オーソペディック・インコーポレーテッド Osteogenic paste composition and use thereof
GB9902976D0 (en) 1999-02-11 1999-03-31 Giltech Ltd Composite
US6436143B1 (en) * 1999-02-22 2002-08-20 Anthony C. Ross Method and apparatus for treating intervertebral disks
US6264659B1 (en) * 1999-02-22 2001-07-24 Anthony C. Ross Method of treating an intervertebral disk
US6206921B1 (en) * 1999-02-22 2001-03-27 Peter A. Guagliano Method of replacing nucleus pulposus and repairing the intervertebral disk
US6428576B1 (en) * 1999-04-16 2002-08-06 Endospine, Ltd. System for repairing inter-vertebral discs
US6805697B1 (en) * 1999-05-07 2004-10-19 University Of Virginia Patent Foundation Method and system for fusing a spinal region
US6921412B1 (en) * 1999-05-18 2005-07-26 Cryolife, Inc. Self-supporting, shaped, three-dimensional biopolymeric materials and methods
US6425919B1 (en) * 1999-08-18 2002-07-30 Intrinsic Orthopedics, Inc. Devices and methods of vertebral disc augmentation
US6264695B1 (en) 1999-09-30 2001-07-24 Replication Medical, Inc. Spinal nucleus implant
US6332894B1 (en) * 2000-03-07 2001-12-25 Zimmer, Inc. Polymer filled spinal fusion cage
US6723335B1 (en) * 2000-04-07 2004-04-20 Jeffrey William Moehlenbruck Methods and compositions for treating intervertebral disc degeneration
ES2358498T3 (en) * 2000-10-24 2011-05-11 Cryolife, Inc. Bioprosthetic filling and methods, particularly for the in situ formation of intervertebral discs bioprosthesis.
US7183369B1 (en) * 2003-02-14 2007-02-27 Iowa State University Research Foundation, Inc. Injectible bodily prosthetics employing methacrylic copolymer gels

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5824093A (en) * 1994-10-17 1998-10-20 Raymedica, Inc. Prosthetic spinal disc nucleus
US5766584A (en) * 1995-06-02 1998-06-16 Massachusetts Institute Of Technology Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells
US5874500A (en) * 1995-12-18 1999-02-23 Cohesion Technologies, Inc. Crosslinked polymer compositions and methods for their use
US6395032B1 (en) * 1998-12-11 2002-05-28 Dimso (Distribution Medicale Du Sud-Ouest) Intervertebral disc prosthesis with liquid chamber
US20040091540A1 (en) * 2000-11-15 2004-05-13 Desrosiers Eric Andre Method for restoring a damaged or degenerated intervertebral disc
US6936070B1 (en) * 2001-01-17 2005-08-30 Nabil L. Muhanna Intervertebral disc prosthesis and methods of implantation
US20060089721A1 (en) * 2001-01-17 2006-04-27 Muhanna Nabil L Intervertebral disc prosthesis and methods of implantation
US6488952B1 (en) * 2001-08-28 2002-12-03 John P. Kennedy Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
US7004945B2 (en) * 2001-11-01 2006-02-28 Spinewave, Inc. Devices and methods for the restoration of a spinal disc
US20070173943A1 (en) * 2003-01-17 2007-07-26 Dulak Gary R Artificial nucleus pulposus and method of injecting same
US20040220296A1 (en) * 2003-04-30 2004-11-04 Lowman Anthony M. Thermogelling polymer blends for biomaterial applications

Cited By (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9668875B2 (en) 1999-03-07 2017-06-06 Nuvasive, Inc. Method and apparatus for computerized surgery
US7749275B2 (en) 1999-08-18 2010-07-06 Intrinsic Therapeutics, Inc. Method of reducing spinal implant migration
US20030014118A1 (en) * 1999-08-18 2003-01-16 Lambrecht Gregory H. Implant for reinforcing and annulus fibrosis
US20030093155A1 (en) * 1999-08-18 2003-05-15 Lambrecht Gregory H. Deployment devices and methods for vertebral disc augmentation
US9333087B2 (en) 1999-08-18 2016-05-10 Intrinsic Therapeutics, Inc. Herniated disc repair
US8409284B2 (en) 1999-08-18 2013-04-02 Intrinsic Therapeutics, Inc. Methods of repairing herniated segments in the disc
US8025698B2 (en) 1999-08-18 2011-09-27 Intrinsic Therapeutics, Inc. Method of rehabilitating an anulus fibrosus
US20040024465A1 (en) * 1999-08-18 2004-02-05 Gregory Lambrecht Devices and method for augmenting a vertebral disc
US20040030392A1 (en) * 1999-08-18 2004-02-12 Lambrecht Greg. H. Method of supporting nucleus pulposus
US20040034429A1 (en) * 1999-08-18 2004-02-19 Lambrecht Gregg H, Anchored anulus method
US20060217812A1 (en) * 1999-08-18 2006-09-28 Lambrecht Greg H Method of anchoring an implant in an intervertebral disc
US8021425B2 (en) 1999-08-18 2011-09-20 Intrinsic Therapeutics, Inc. Versatile method of repairing an intervertebral disc
US20040097924A1 (en) * 1999-08-18 2004-05-20 Gregory Lambrecht Devices and method for augmenting a vertebral disc
US20030009227A1 (en) * 1999-08-18 2003-01-09 Lambrecht Gregory H. Methods of reinforcing an annulus fibrosis
US20050234557A1 (en) * 1999-08-18 2005-10-20 Lambrecht Gregory H Stabilized intervertebral disc barrier
US8002836B2 (en) 1999-08-18 2011-08-23 Intrinsic Therapeutics, Inc. Method for the treatment of the intervertebral disc anulus
US7879097B2 (en) 1999-08-18 2011-02-01 Intrinsic Therapeutics, Inc. Method of performing a procedure within a disc
US20020151979A1 (en) * 1999-08-18 2002-10-17 Lambrecht Greg H. Devices and method for nucleus pulposus augmentation and retention
US7998213B2 (en) 1999-08-18 2011-08-16 Intrinsic Therapeutics, Inc. Intervertebral disc herniation repair
US7959679B2 (en) 1999-08-18 2011-06-14 Intrinsic Therapeutics, Inc. Intervertebral anulus and nucleus augmentation
US8231678B2 (en) 1999-08-18 2012-07-31 Intrinsic Therapeutics, Inc. Method of treating a herniated disc
US20040044412A1 (en) * 1999-08-18 2004-03-04 Gregory Lambrecht Devices and method for augmenting a vertebral disc
US20050004578A1 (en) * 1999-08-18 2005-01-06 Lambrecht Gregory H. Apparatus delivery in an intervertebral disc
US20050038519A1 (en) * 1999-08-18 2005-02-17 Lambrecht Gregory H. Method of reducing spinal implant migration
US9706947B2 (en) 1999-08-18 2017-07-18 Intrinsic Therapeutics, Inc. Method of performing an anchor implantation procedure within a disc
US20050060038A1 (en) * 1999-08-18 2005-03-17 Lambrecht Gregory E. Flexible implant for intervertebral disc repair
US7658765B2 (en) 1999-08-18 2010-02-09 Intrinsic Therapeutics, Inc. Resilient intervertebral disc implant
US7867278B2 (en) 1999-08-18 2011-01-11 Intrinsic Therapeutics, Inc. Intervertebral disc anulus implant
US8257437B2 (en) 1999-08-18 2012-09-04 Intrinsic Therapeutics, Inc. Methods of intervertebral disc augmentation
US7717961B2 (en) 1999-08-18 2010-05-18 Intrinsic Therapeutics, Inc. Apparatus delivery in an intervertebral disc
US7258700B2 (en) 1999-08-18 2007-08-21 Intrinsic Therapeutics, Inc. Devices and method for nucleus pulposus augmentation and retention
US7753941B2 (en) 2000-04-04 2010-07-13 Anulex Technologies, Inc. Devices and methods for annular repair of intervertebral discs
US7905923B2 (en) 2000-04-04 2011-03-15 Anulex Technologies, Inc. Devices and methods for annular repair of intervertebral discs
US20050002909A1 (en) * 2000-04-07 2005-01-06 Centerpulse Biologics Inc Methods and compositions for treating intervertebral disc degeneration
US7144397B2 (en) 2000-08-18 2006-12-05 Intrinsic Therapeutics, Inc. Minimally invasive system for manipulating intervertebral disc tissue
US20040133229A1 (en) * 2000-08-18 2004-07-08 Lambrecht Gregory H. Minimally invasive system for manipulating intervertebral disc tissue
US20040138673A1 (en) * 2000-08-18 2004-07-15 Lambrecht Gregory H. Lateral probe advancement in intervertebral disc tissue
US20030153927A1 (en) * 2001-05-15 2003-08-14 Endius Incorporated Structure for receiving surgical instruments
US20030181365A1 (en) * 2002-03-19 2003-09-25 Slivka Michael Andrew Method for nonsurgical treatment of the intervertebral disc and kit therefor
US20050209699A1 (en) * 2002-03-19 2005-09-22 Slivka Michael A Method for nonsurgical treatment of the nucleus pulposus of the intervertebral disc using genipin or proanthrocyanidin, and kit therefor
US6812211B2 (en) * 2002-03-19 2004-11-02 Michael Andrew Slivka Method for nonsurgical treatment of the intervertebral disc and kit therefor
US7294617B2 (en) 2002-03-19 2007-11-13 Depuy Acromed, Inc. Method for nonsurgical treatment of the intervertebral disc and kit therefor
US20050038518A1 (en) * 2002-03-19 2005-02-17 Depuy Spine, Inc. Method for nonsurgical treatment of the intervertebral disc and kit therefor
US9351852B2 (en) 2002-05-23 2016-05-31 Pioneer Surgical Technology, Inc. Artificial disc device
US20030220691A1 (en) * 2002-05-23 2003-11-27 Pioneer Laboratories, Inc. Artificial intervertebral disc device
US8262731B2 (en) 2002-05-23 2012-09-11 Pioneer Surgical Technology, Inc. Artificial disc device
US8241360B2 (en) 2002-05-23 2012-08-14 Pioneer Surgical Technology, Inc. Artificial disc device
US8388684B2 (en) 2002-05-23 2013-03-05 Pioneer Signal Technology, Inc. Artificial disc device
US20050192671A1 (en) * 2002-05-23 2005-09-01 Pioneer Laboratories, Inc. Artificial disc device
US20050119754A1 (en) * 2002-09-18 2005-06-02 Trieu Hai H. Compositions and methods for treating intervertebral discs with collagen-based materials
US20040228901A1 (en) * 2002-09-18 2004-11-18 Trieu Hai H. Collagen-based materials and methods for treating synovial joints
US7713303B2 (en) 2002-09-18 2010-05-11 Warsaw Orthopedic, Inc. Collagen-based materials and methods for augmenting intervertebral discs
US20050197707A1 (en) * 2002-09-18 2005-09-08 Trieu Hai H. Collagen-based materials and methods for augmenting intervertebral discs
US7744651B2 (en) 2002-09-18 2010-06-29 Warsaw Orthopedic, Inc Compositions and methods for treating intervertebral discs with collagen-based materials
US20040230305A1 (en) * 2002-09-24 2004-11-18 Bogomir Gorensek Stabilizing device for intervertebral disc, and methods thereof
US7201775B2 (en) 2002-09-24 2007-04-10 Bogomir Gorensek Stabilizing device for intervertebral disc, and methods thereof
US6932843B2 (en) 2002-09-25 2005-08-23 Medicinelodge, Inc. Apparatus and method for the in-situ formation of a structural prosthesis
WO2004028414A1 (en) 2002-09-25 2004-04-08 Medicinelodge, Inc. Apparatus and method for the in-situ formation of a structural prosthesis
US20070134343A1 (en) * 2002-11-15 2007-06-14 Trieu Hai H Collagen-based materials and methods for treating synovial joints
US7731981B2 (en) 2002-11-15 2010-06-08 Warsaw Orthopedic, Inc. Collagen-based materials and methods for treating synovial joints
US20040186471A1 (en) * 2002-12-07 2004-09-23 Sdgi Holdings, Inc. Method and apparatus for intervertebral disc expansion
US20070173943A1 (en) * 2003-01-17 2007-07-26 Dulak Gary R Artificial nucleus pulposus and method of injecting same
US20070003525A1 (en) * 2003-01-31 2007-01-04 Moehlenbruck Jeffrey W Hydrogel compositions comprising nucleus pulposus tissue
US20040260300A1 (en) * 2003-06-20 2004-12-23 Bogomir Gorensek Method of delivering an implant through an annular defect in an intervertebral disc
US20040260305A1 (en) * 2003-06-20 2004-12-23 Bogomir Gorensek Device for delivering an implant through an annular defect in an intervertebral disc
US7727241B2 (en) 2003-06-20 2010-06-01 Intrinsic Therapeutics, Inc. Device for delivering an implant through an annular defect in an intervertebral disc
US20060247785A1 (en) * 2003-06-20 2006-11-02 Bogomir Gorensek Method for delivering and positioning implants in the intervertebral disc environment
US20050071012A1 (en) * 2003-09-30 2005-03-31 Hassan Serhan Methods and devices to replace spinal disc nucleus pulposus
US7655012B2 (en) 2003-10-02 2010-02-02 Zimmer Spine, Inc. Methods and apparatuses for minimally invasive replacement of intervertebral discs
US9445916B2 (en) 2003-10-22 2016-09-20 Pioneer Surgical Technology, Inc. Joint arthroplasty devices having articulating members
US20050116400A1 (en) * 2003-11-14 2005-06-02 White Moreno J. Non-linear fiber/matrix architecture
WO2005049308A3 (en) * 2003-11-14 2007-04-05 Moreno J White Non-linear fiber/matrix architecture
WO2005049308A2 (en) * 2003-11-14 2005-06-02 White Moreno J Non-linear fiber/matrix architecture
US8317802B1 (en) 2004-01-08 2012-11-27 Spine Wave, Inc. System for distracting opposing vertebral bodies of a spine
US8246630B2 (en) 2004-01-08 2012-08-21 Spine Wave, Inc. Apparatus and method for injecting fluent material at a distracted tissue site
US20050182414A1 (en) * 2004-01-08 2005-08-18 Richard Manzi Apparatus and method for injecting fluent material at a distracted tissue site
US7789912B2 (en) * 2004-01-08 2010-09-07 Spine Wave, Inc. Apparatus and method for injecting fluent material at a distracted tissue site
US20110004217A1 (en) * 2004-01-08 2011-01-06 Spine Wave, Inc. Apparatus and Method for Injecting Fluent Material at a Distracted Tissue Site
US8197544B1 (en) 2004-01-08 2012-06-12 Spine Wave, Inc. Method for distracting opposing vertebral bodies of a spine
US7985781B2 (en) 2004-10-12 2011-07-26 Zimmer Gmbh PVA hydrogel
US8017139B2 (en) 2005-02-23 2011-09-13 Zimmer Technology, Inc. Blend hydrogels and methods of making
US20060188487A1 (en) * 2005-02-23 2006-08-24 Zimmer Technology, Inc. Blend hydrogels and methods of making
US20060287727A1 (en) * 2005-06-15 2006-12-21 Jerome Segal Mechanical apparatus and method for artificial disc replacement
US7442210B2 (en) * 2005-06-15 2008-10-28 Jerome Segal Mechanical apparatus and method for artificial disc replacement
US20070100349A1 (en) * 2005-10-27 2007-05-03 O'neil Michael Nucleus augmentation delivery device and technique
US9162041B2 (en) 2005-10-27 2015-10-20 DePuy Synthes Products, Inc. Nucleus augmentation delivery device and technique
US8357199B2 (en) 2005-10-27 2013-01-22 Depuy Spine, Inc. Nucleus augmentation delivery device and technique
US8197545B2 (en) 2005-10-27 2012-06-12 Depuy Spine, Inc. Nucleus augmentation delivery device and technique
US8262730B2 (en) 2005-12-07 2012-09-11 Zimmer, Inc. Methods of bonding or modifying hydrogels using irradiation
US20070134333A1 (en) * 2005-12-07 2007-06-14 Zimmer, Inc. Methods of bonding or modifying hydrogels using irradiation
US8017107B2 (en) 2005-12-22 2011-09-13 Zimmer, Inc. Perfluorocyclobutane crosslinked hydrogels
US7972337B2 (en) 2005-12-28 2011-07-05 Intrinsic Therapeutics, Inc. Devices and methods for bone anchoring
US9039741B2 (en) 2005-12-28 2015-05-26 Intrinsic Therapeutics, Inc. Bone anchor systems
US9610106B2 (en) 2005-12-28 2017-04-04 Intrinsic Therapeutics, Inc. Bone anchor systems
US8114082B2 (en) 2005-12-28 2012-02-14 Intrinsic Therapeutics, Inc. Anchoring system for disc repair
US8394146B2 (en) 2005-12-28 2013-03-12 Intrinsic Therapeutics, Inc. Vertebral anchoring methods
US20070203579A1 (en) * 2006-02-27 2007-08-30 Sdgi Holdings, Inc. Prosthetic device for spinal arthroplasty
US7918889B2 (en) 2006-02-27 2011-04-05 Warsaw Orthopedic, Inc. Expandable spinal prosthetic devices and associated methods
US8110242B2 (en) 2006-03-24 2012-02-07 Zimmer, Inc. Methods of preparing hydrogel coatings
US20070233245A1 (en) * 2006-03-31 2007-10-04 Sdgi Holdings, Inc. Methods and instruments for delivering intervertebral devices
US20090275913A1 (en) * 2006-04-27 2009-11-05 Warsaw Orthopedic, Inc. Devices, apparatus, and methods for bilateral approach to disc augmentation
US8133279B2 (en) 2006-04-27 2012-03-13 Warsaw Orthopedic, Inc. Methods for treating an annulus defect of an intervertebral disc
US20070255406A1 (en) * 2006-04-27 2007-11-01 Sdgi Holdings, Inc. Devices, apparatus, and methods for bilateral approach to disc augmentation
US8157863B2 (en) 2006-04-27 2012-04-17 Warsaw Orthopedic, Inc. Devices, apparatus, and methods for bilateral approach to disc augmentation
US20070255286A1 (en) * 2006-04-27 2007-11-01 Sdgi Holdings, Inc. Devices, apparatus, and methods for improved disc augmentation
US20080004431A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic Inc Method of manufacturing an injectable collagen material
US8399619B2 (en) 2006-06-30 2013-03-19 Warsaw Orthopedic, Inc. Injectable collagen material
US8118779B2 (en) 2006-06-30 2012-02-21 Warsaw Orthopedic, Inc. Collagen delivery device
US20080004570A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic, Inc. Collagen delivery device
US20080004703A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic, Inc. Method of treating a patient using a collagen material
US20080004214A1 (en) * 2006-06-30 2008-01-03 Warsaw Orthopedic, Inc Injectable collagen material
US8518049B2 (en) 2006-07-27 2013-08-27 Lanx, Inc. Methods and apparatuses for facilitating percutaneous fusion
US7758649B2 (en) * 2006-08-04 2010-07-20 Integrity Intellect Inc. Reversibly deformable implant
US20080033575A1 (en) * 2006-08-04 2008-02-07 Christopher Walsh Reversibly deformable implant
US9233011B2 (en) 2006-09-15 2016-01-12 Pioneer Surgical Technology, Inc. Systems and apparatuses for inserting an implant in intervertebral space
US9693872B2 (en) 2006-09-15 2017-07-04 Pioneer Surgical Technology, Inc. Intervertebral disc implant
US20080268056A1 (en) * 2007-04-26 2008-10-30 Abhijeet Joshi Injectable copolymer hydrogel useful for repairing vertebral compression fractures
US20080269897A1 (en) * 2007-04-26 2008-10-30 Abhijeet Joshi Implantable device and methods for repairing articulating joints for using the same
US20100184223A1 (en) * 2007-07-13 2010-07-22 Helmut Wurst Biomaterial based on a hydrophilic polymeric carrier
US8236342B2 (en) 2007-08-03 2012-08-07 Zimmer, Inc. Multi-polymer hydrogels
US7731988B2 (en) 2007-08-03 2010-06-08 Zimmer, Inc. Multi-polymer hydrogels
US20100204800A1 (en) * 2007-08-03 2010-08-12 Zimmer, Inc. Multi-polymer hydrogels
US8062739B2 (en) 2007-08-31 2011-11-22 Zimmer, Inc. Hydrogels with gradient
US8323341B2 (en) 2007-09-07 2012-12-04 Intrinsic Therapeutics, Inc. Impaction grafting for vertebral fusion
US8454612B2 (en) 2007-09-07 2013-06-04 Intrinsic Therapeutics, Inc. Method for vertebral endplate reconstruction
US9226832B2 (en) 2007-09-07 2016-01-05 Intrinsic Therapeutics, Inc. Interbody fusion material retention methods
US8361155B2 (en) 2007-09-07 2013-01-29 Intrinsic Therapeutics, Inc. Soft tissue impaction methods
US20090093852A1 (en) * 2007-10-05 2009-04-09 Hynes Richard A Spinal stabilization treatment methods for maintaining axial spine height and sagital plane spine balance
US7947784B2 (en) 2007-11-16 2011-05-24 Zimmer, Inc. Reactive compounding of hydrogels
US8034362B2 (en) 2008-01-04 2011-10-11 Zimmer, Inc. Chemical composition of hydrogels for use as articulating surfaces
US20100322993A1 (en) * 2008-01-28 2010-12-23 Nmi Naturwissenschaftliches Und Medizinisches Institut An Der Universitaet Tuebingen Injectable biocompatible composition
US20090222096A1 (en) * 2008-02-28 2009-09-03 Warsaw Orthopedic, Inc. Multi-compartment expandable devices and methods for intervertebral disc expansion and augmentation
US20090297603A1 (en) * 2008-05-29 2009-12-03 Abhijeet Joshi Interspinous dynamic stabilization system with anisotropic hydrogels
US8764829B2 (en) * 2008-06-04 2014-07-01 James Marvel Buffer for a human joint and method of arthroscopically inserting
US20110270393A1 (en) * 2008-06-04 2011-11-03 James Marvel Buffer for a human joint and method of arthroscopically inserting
US9241807B2 (en) 2011-12-23 2016-01-26 Pioneer Surgical Technology, Inc. Systems and methods for inserting a spinal device
WO2014074870A1 (en) * 2012-11-08 2014-05-15 Edwards Lifesciences Corporation Methods for treating bioprosthetic tissue using a nucleophile/electrophile in a catalytic system

Also Published As

Publication number Publication date Type
ES2358498T3 (en) 2011-05-11 grant
CA2422884A1 (en) 2002-05-02 application
CA2422884C (en) 2009-05-19 grant
WO2002034111A2 (en) 2002-05-02 application
EP1328220A2 (en) 2003-07-23 application
EP1328220B1 (en) 2011-01-05 grant
US7621954B2 (en) 2009-11-24 grant
JP4202749B2 (en) 2008-12-24 grant
JP2004532656A (en) 2004-10-28 application
US20080058942A1 (en) 2008-03-06 application
DE60143804D1 (en) 2011-02-17 grant
US7621959B2 (en) 2009-11-24 grant
US7896920B2 (en) 2011-03-01 grant
US20050102030A1 (en) 2005-05-12 application
US20070093902A1 (en) 2007-04-26 application
EP1328220A4 (en) 2009-08-19 application
WO2002034111A3 (en) 2003-01-16 application

Similar Documents

Publication Publication Date Title
Szpalski et al. Spine arthroplasty: a historical review
Von Schroeder et al. The use of polylactic acid matrix and periosteal grafts for the reconstruction of rabbit knee articular defects
US5298254A (en) Shaped, swollen demineralized bone and its use in bone repair
US7723395B2 (en) Compressed porous materials suitable for implant
US5824093A (en) Prosthetic spinal disc nucleus
US5501706A (en) Medical implant structure and method for using the same
US5514137A (en) Fixation of orthopedic devices
US6511511B1 (en) Fiber-reinforced, porous, biodegradable implant device
US6371988B1 (en) Bone grafts
US6306177B1 (en) Biomaterial system for in situ tissue repair
US7879109B2 (en) Continuous phase composite for musculoskeletal repair
US7004945B2 (en) Devices and methods for the restoration of a spinal disc
US6083522A (en) Devices for tissue repair and methods for preparation and use thereof
US7066960B1 (en) Intervertebral disk replacement
US5769897A (en) Synthetic bone
US7879103B2 (en) Vertebral disc repair
US20040243242A1 (en) Implant derived from bone
US20050123581A1 (en) Compressed high density fibrous polymers suitable for implant
Hing et al. Quantification of bone ingrowth within bone-derived porous hydroxyapatite implants of varying density
US20070282455A1 (en) Prosthetic Device For Cartilage Repair
US20110054408A1 (en) Delivery systems, devices, tools, and methods of use
US20070142916A1 (en) Bone graft composition, method and implant
US20050130929A1 (en) System and method for the pretreatment of the endplates of an intervertebral disc
US6719797B1 (en) Nucleus augmentation with in situ formed hydrogels
US20050043808A1 (en) Knee joint prosthesis

Legal Events

Date Code Title Description
AS Assignment

Owner name: CRYOLIFE, INC., GEORGIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:YUKSEL, K. UMIT;WALSH, STEVEN P.;BLACK, KIRBY S.;REEL/FRAME:012347/0968;SIGNING DATES FROM 20011101 TO 20011107

AS Assignment

Owner name: WELLS FARGO FOOTHILL, INC., GEORGIA

Free format text: SECURITY AGREEMENT;ASSIGNORS:CRYOLIFE, INC.;CRYOLIFE TECHNOLOGY, INC.;REEL/FRAME:016256/0042

Effective date: 20050208

AS Assignment

Owner name: CRYOLIFE, INC., GEORGIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WELLS FARGO FOOTHILL, INC.;REEL/FRAME:020580/0036

Effective date: 20080208

AS Assignment

Owner name: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT, MA

Free format text: PATENT SECURITY AGREEMENT;ASSIGNORS:CRYOLIFE, INC.;CRYOLIFE ACQUISITION CORPORATION;REEL/FRAME:020723/0392

Effective date: 20080327

AS Assignment

Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR

Free format text: ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT;ASSIGNOR:GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT;REEL/FRAME:037146/0466

Effective date: 20151118

AS Assignment

Owner name: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS AGENT, MAR

Free format text: SECURITY INTEREST;ASSIGNORS:CRYOLIFE, INC., AS GRANTOR;VALVE SPECIAL PURPOSE CO., LLC, AS GRANTOR;ON-X LIFE TECHNOLOGIES, INC., AS GRANTOR;REEL/FRAME:037569/0212

Effective date: 20160120

AS Assignment

Owner name: CRYOLIFE ACQUISITION CORPORATION, GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: CRYOLIFE, INC., GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: ON-X LIFE TECHNOLOGIES, INC. (F/K/A MCRI, INC.), G

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: CARDIOGENESIS CORPORATION (N/K/A CRYOLIFE, INC.),

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: HEMOSPHERE, INC., GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201

Owner name: VALVE SPECIAL PURPOSE CO., LLC, GEORGIA

Free format text: RELEASE OF SECURITY INTEREST IN PATENTS;ASSIGNOR:HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS ADMINISTRATIVE AGENT;REEL/FRAME:044621/0240

Effective date: 20171201